• Regenxbio Chief Medical Officer Steve Pakola sold 19,608 shares on June 29, 2026 at USD 11.04.
• Pakola exercised stock options for 36,725 shares on July 1, 2026 at USD 7.86.
• He sold 36,725 shares the same day at USD 12.86.
• Directly held common stock totaled 213,009 shares after the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenxbio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001700659-26-000012), on July 01, 2026, and is solely responsible for the information contained therein.